status: 200
content-location: http://rest.kegg.jp/get/map05150
server: Apache
date: Wed, 15 Oct 2014 15:09:24 GMT
content-type: text/plain

ENTRY       map05150                    Pathway
NAME        Staphylococcus aureus infection
DESCRIPTION Staphylococcus aureus can cause multiple forms of infections ranging from superficial skin infections to food poisoning and life-threatening infections. The organism has several ways to divert the effectiveness of the immune system: secreting immune modulating proteins that inhibit complement activation and neutrophil chemotaxis or lysis, modulating the sensitivity to cationic antimicrobial peptides (such as defensin) by increasing the positive net charge of its cytoplasmic membrane, and expression of superantigens that prevent development of a normal immune response or cause an emetic response when ingested.
CLASS       Human Diseases; Infectious diseases
PATHWAY_MAP map05150  Staphylococcus aureus infection
DISEASE     H00330  Methicillin-resistant Staphylococcal aureus (MRSA) infection
            H00331  Vancomycin-resistant Staphylococcal aureus (VRSA) infection
REFERENCE   PMID:20178484
  AUTHORS   Foster TJ
  TITLE     Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion.
  JOURNAL   Vet Dermatol 20:456-70 (2009)
REFERENCE   PMID:16322743
  AUTHORS   Foster TJ
  TITLE     Immune evasion by staphylococci.
  JOURNAL   Nat Rev Microbiol 3:948-58 (2005)
REFERENCE   PMID:20062962
  AUTHORS   Laarman A, Milder F, van Strijp J, Rooijakkers S
  TITLE     Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.
  JOURNAL   J Mol Med 88:115-20 (2010)
REFERENCE   PMID:16242332
  AUTHORS   Rooijakkers SH, van Kessel KP, van Strijp JA
  TITLE     Staphylococcal innate immune evasion.
  JOURNAL   Trends Microbiol 13:596-601 (2005)
REFERENCE   PMID:16679003
  AUTHORS   Iwatsuki K, Yamasaki O, Morizane S, Oono T
  TITLE     Staphylococcal cutaneous infections: invasion, evasion and aggression.
  JOURNAL   J Dermatol Sci 42:203-14 (2006)
REFERENCE   PMID:11361034
  AUTHORS   Torres BA, Kominsky S, Perrin GQ, Hobeika AC, Johnson HM
  TITLE     Superantigens: the good, the bad, and the ugly.
  JOURNAL   Exp Biol Med (Maywood) 226:164-76 (2001)
REFERENCE   PMID:18061675
  AUTHORS   Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S, Jenkins AT, Feil EJ, van den Elsen JM
  TITLE     S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.
  JOURNAL   Mol Immunol 45:1600-11 (2008)
REFERENCE   PMID:16724100
  AUTHORS   Silverman GJ, Goodyear CS
  TITLE     Confounding B-cell defences: lessons from a staphylococcal superantigen.
  JOURNAL   Nat Rev Immunol 6:465-75 (2006)
REFERENCE   PMID:15273292
  AUTHORS   Goodyear CS, Silverman GJ
  TITLE     Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes.
  JOURNAL   Proc Natl Acad Sci U S A 101:11392-7 (2004)
REFERENCE   PMID:19112495
  AUTHORS   Haupt K, Reuter M, van den Elsen J, Burman J, Halbich S, Richter J, Skerka C, Zipfel PF
  TITLE     The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a  tripartite complex with host complement Factor H and C3b.
  JOURNAL   PLoS Pathog 4:e1000250 (2008)
REFERENCE   PMID:16111912
  AUTHORS   Bokarewa MI, Jin T, Tarkowski A
  TITLE     Staphylococcus aureus: Staphylokinase.
  JOURNAL   Int J Biochem Cell Biol 38:504-9 (2006)
REFERENCE   PMID:16086019
  AUTHORS   Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP, van Strijp JA
  TITLE     Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
  JOURNAL   Nat Immunol 6:920-7 (2005)
REFERENCE   PMID:19503103
  AUTHORS   Rooijakkers SH, Wu J, Ruyken M, van Domselaar R, Planken KL, Tzekou A, Ricklin D, Lambris JD, Janssen BJ, van Strijp JA, Gros P
  TITLE     Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
  JOURNAL   Nat Immunol 10:721-7 (2009)
REFERENCE   PMID:17893203
  AUTHORS   Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH
  TITLE     Staphylococcal complement evasion by various convertase-blocking molecules.
  JOURNAL   J Exp Med 204:2461-71 (2007)
REFERENCE   PMID:18544012
  AUTHORS   Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM
  TITLE     Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b.
  JOURNAL   J Infect Dis 198:125-33 (2008)
REFERENCE   PMID:16640587
  AUTHORS   Higgins J, Loughman A, van Kessel KP, van Strijp JA, Foster TJ
  TITLE     Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.
  JOURNAL   FEMS Microbiol Lett 258:290-6 (2006)
REFERENCE   PMID:20133685
  AUTHORS   Laursen NS, Gordon N, Hermans S, Lorenz N, Jackson N, Wines B, Spillner E, Christensen JB, Jensen M, Fredslund F, Bjerre M, Sottrup-Jensen L, Fraser JD, Andersen GR
  TITLE     Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus.
  JOURNAL   Proc Natl Acad Sci U S A 107:3681-6 (2010)
REFERENCE   PMID:17848512
  AUTHORS   Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser JD, Wines BD
  TITLE     Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
  JOURNAL   Proc Natl Acad Sci U S A 104:15051-6 (2007)
REFERENCE   PMID:14993252
  AUTHORS   de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP, van Strijp JA
  TITLE     Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.
  JOURNAL   J Exp Med 199:687-95 (2004)
REFERENCE   PMID:17114475
  AUTHORS   Prat C, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP
  TITLE     A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.
  JOURNAL   J Immunol 177:8017-26 (2006)
REFERENCE   PMID:17132726
  AUTHORS   Bestebroer J, Poppelier MJ, Ulfman LH, Lenting PJ, Denis CV, van Kessel KP, van Strijp JA, de Haas CJ
  TITLE     Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated  neutrophil rolling.
  JOURNAL   Blood 109:2936-43 (2007)
REFERENCE   PMID:18045383
  AUTHORS   Chung MC, Wines BD, Baker H, Langley RJ, Baker EN, Fraser JD
  TITLE     The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition.
  JOURNAL   Mol Microbiol 66:1342-55 (2007)
REFERENCE   PMID:12091905
  AUTHORS   Chavakis T, Hussain M, Kanse SM, Peters G, Bretzel RG, Flock JI, Herrmann M, Preissner KT
  TITLE     Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes.
  JOURNAL   Nat Med 8:687-93 (2002)
REFERENCE   PMID:17517597
  AUTHORS   Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M
  TITLE     Gram-positive three-component antimicrobial peptide-sensing system.
  JOURNAL   Proc Natl Acad Sci U S A 104:9469-74 (2007)
REFERENCE   PMID:15561843
  AUTHORS   Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J
  TITLE     Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.
  JOURNAL   Antimicrob Agents Chemother 48:4673-9 (2004)
REFERENCE   PMID:18837785
  AUTHORS   Fraser JD, Proft T
  TITLE     The bacterial superantigen and superantigen-like proteins.
  JOURNAL   Immunol Rev 225:226-43 (2008)
REFERENCE   PMID:12228315
  AUTHORS   Yamaguchi T, Nishifuji K, Sasaki M, Fudaba Y, Aepfelbacher M, Takata T, Ohara M, Komatsuzawa H, Amagai M, Sugai M
  TITLE     Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B.
  JOURNAL   Infect Immun 70:5835-45 (2002)
REFERENCE   PMID:16710608
  AUTHORS   Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J
  TITLE     Human beta-defensins.
  JOURNAL   Cell Mol Life Sci 63:1294-313 (2006)
REFERENCE   PMID:16184199
  AUTHORS   Zhang Q, Mousdicas N, Yi Q, Al-Hassani M, Billings SD, Perkins SM, Howard KM, Ishii S, Shimizu T, Travers JB
  TITLE     Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
  JOURNAL   J Clin Invest 115:2855-61 (2005)
REFERENCE   PMID:15372083
  AUTHORS   Lehrer RI
  TITLE     Primate defensins.
  JOURNAL   Nat Rev Microbiol 2:727-38 (2004)
KO_PATHWAY  ko05150
///
